The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N -butyldeoxynojirimycin
Open accessAbstract
Sandhoff disease is a neurodegenerative disorder resulting from the autosomal recessive inheritance of mutations in the HEXB gene, which encodes the β-subunit of β-hexosaminidase. G M2 ganglioside fails to be degraded and accumulates within lysosomes in cells of the periphery and the central nervous system (CNS). There are currently no therapies for the glycosphingolipid lysosomal storage diseases that involve CNS pathology, including the G M2 gangliosidoses. One strategy for treating this and related diseases is substrate deprivation. This would utilize an inhibitor of glycosphingolipid biosynthesis to balance synthesis with the impaired rate of catabolism, thus preventing storage. One such inhibitor is N -butyldeoxynojirimycin, which currently is in clinical trials for the potential treatment of type 1 Gaucher disease, a related disease that involves glycosphingolipid storage in peripheral tissues, but not in the CNS. In this study, we have evaluated whether this drug also could be applied to the treatment of diseases with CNS storage and pathology. We therefore have treated a mouse model of Sandhoff disease with the inhibitor N -butyldeoxynojirimycin. The treated mice have delayed symptom onset, reduced storage in the brain and peripheral tissues, and increased life expectancy. Substrate deprivation therefore offers a potentially general therapy for this family of lysosomal storage diseases, including those with CNS disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Linear and Nonlinear Models for the Analysis of Repeated Measurements
Vonesh, E., & Chinchilli, V. M. (1996) · CRC Press eBooks · doi:10.1201/9781482293272 · Cited by 989
Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-170 · Cited by 468
Self-citationN-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
Platt, F. M., Neises, G. R., Dwek, R. A., & Butters, T. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37202-2 · Cited by 455
Self-citationGrabowski, G. A., Barton, N. W., Pastores, G., Dambrosia, J. M., Banerjee, T. K., McKee, M. A., Parker, C., Schiffmann, R., Hill, S. C., & Brady, R. O. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00005 · Cited by 446
Prevention of Lysosomal Storage in Tay-Sachs Mice Treated with N -Butyldeoxynojirimycin
Platt, F. M., Neises, G. R., Reinkensmeier, G., Townsend, M. J., Perry, V. H., Proia, R. L., Winchester, B., Dwek, R. A., & Butters, T. D. (1997) · Science · doi:10.1126/science.276.5311.428 · Cited by 340
Self-citationAllogeneic bone marrow transplantation for lysosomal storage diseases
Hoogerbrugge, P. M., Brouwer, O. F., Bordigoni, P., Cornu, G., Kapaun, P., Ortega, J. J., O'Meara, A., Souillet, G., Frappaz, D., Blanche, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92597-x · Cited by 256
Krivit, W. (1995) · Cell Transplantation · doi:10.1016/0963-6897(95)00021-o · Cited by 208
Platt, F. M., Neises, G. R., Karlsson, G. B., Dwek, R. A., & Butters, T. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47132-3 · Cited by 175
Self-citationEnzyme replacement therapy for Gaucher disease
Beutler, E., Kay, A., Saven, A., Garver, P., Thurston, D., Dawson, A., & Rosenbloom, B. (1991) · Blood · doi:10.1182/blood.v78.5.1183.1183 · Cited by 169
Huang, J.-Q., Trasler, J. M., Igdoura, S., Michaud, J., Hanai, N., & Gravel, R. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1879 · Cited by 167
Norflus, F., Tifft, C. J., McDonald, M. P., Goldstein, G., Crawley, J. N., Hoffmann, A., Sandhoff, K., Suzuki, K., & Proia, R. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2127 · Cited by 160
Self-citationA genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder
Liu, Y., Wada, R., Kawai, H., Sango, K., Deng, C., Tai, T., McDonald, M. P., Araujo, K., Crawley, J. N., Bierfreund, U., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5542 · Cited by 160
Self-citationLiu, Y., Suzuki, K., Reed, J. D., Grinberg, A., Westphal, H., Hoffmann, A., Döring, T. F., Sandhoff, K., & Proia, R. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2503 · Cited by 126
Self-citationPlatt, F. M., Reinkensmeier, G., Dwek, R. A., & Butters, T. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19365 · Cited by 119
Self-citationTreatment of Gaucher disease with an enzyme inhibitor
Radin, N. S. (1996) · Glycoconjugate Journal · doi:10.1007/bf00731489 · Cited by 117
Platt, F. M., & Butters, T. D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00115-4 · Cited by 70
Self-citationThe string test: An early behavioral change in thiamine deficiency
Barclay, L., Gibson, G. E., & Blass, J. P. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90236-7 · Cited by 48
Inhibitors of Glycosphingolipid Biosynthesis.
Platt, F. M., & Butters, T. D. (1995) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.7.495 · Cited by 37
Self-citation
Cited by
Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebícek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02161-9 · Cited by 744
Self-citationPastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
Physiology and pathophysiology of sphingolipid metabolism and signaling
Huwiler, A., Kolter, T., Pfeilschifter, J., & Sandhoff, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00042-1 · Cited by 432
Targeting glycosylation as a therapeutic approach
Dwek, R. A., Butters, T. D., Platt, F. M., & Zitzmann, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd708 · Cited by 420
Self-citationChoudhury, A., Dominguez, M., Puri, V., Sharma, D. K., Narita, K., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15420 · Cited by 407
Metadata
- Authors
- Jeyakumar, M., Butters, T. D., Cortina-Borja, M., Hunnam, V., Proia, R. L., Perry, V. H., Dwek, R. A., & Platt, F. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-05-25
- Volume
- 96
- Issue
- 11
- Pages
- 6388-6393
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1988193452
- Cited by
- 267
- References
- 19
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.